On October 27 2026, Auna transferred its Mexican hospital business to Grupo Salud Auna México Hospitales, S.A. de C.V.; insurance remained with Grupo Salud Auna México, S.A. de C.V., and both businesses remained under Auna’s ultimate ownership.
AUNA · Auna S.A. · Documents
$4.68
+0.09 (+1.96%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$339.92M
Shares
74.06M
Volume · Nov 6
153.84K
Avg daily vol (3M)
173.7K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2026
Oct 28
Current report
6-K
Current report
Oct 22
Current report
6-K
Current report
Auna expects full-year 2026 revenue growth in line with prior guidance, but consolidated Adjusted EBITDA broadly stable year over year due to temporary cost pressure from a Colombian payor contract and advanced-stage cancer cases.
Aug 19
Aug 18
Jul 15
Jul 7
May 27
May 20
May 19
Apr 22
Apr 22
Annual report
20-F
FY2025, ended Dec 31
Annual report for FY2025
AI summary on its way
Revenue 4.39B PEN
▲ unchanged
Net income 97.61M PEN
▼ 11.5%
Diluted EPS 1.32 PEN
▼ 19.0%
Apr 17
Mar 11
Mar 10
Feb 26
2025
Nov 21
Earnings call
Q3 2025 earnings call
Nov 20
Current report
6-K
Current report
Nov 20
Current report
6-K
Current report
Nov 7
Current report
6-K
Current report
Nov 4
Current report
6-K
Current report
Nov 3
Current report
6-K
Current report
Oct 28
Current report
6-K/A
Current report
Oct 28
Current report
6-K
Current report
Oct 28
Current report
6-K
Current report
Oct 21
Current report
6-K
Current report
Sep 24
Current report
6-K
Current report
Aug 20
Earnings call
Q2 2025 earnings call
Aug 19
Current report
6-K
Current report
Jul 16
Current report
6-K
Current report
Jul 1
Current report
6-K
Current report
Jun 30
Current report
6-K
Current report
Jun 6
Current report
6-K
Current report
May 21
Earnings call
Q1 2025 earnings call
May 20
Current report
6-K
Current report
May 8
Current report
6-K
Current report
May 7
Annual report
20-F/A
FY2024, ended Dec 31
Annual report for FY2024
Revenue 4.39B PEN
▲ 13.2%
Net income 110.27M PEN
Diluted EPS 1.63 PEN
May 6
Current report
6-K
Current report
May 5
Registration statement
F-3/A
Registration statement
Apr 17
Registration statement
F-3
Registration statement
Apr 11
Current report
6-K
Current report
Apr 10
Annual report
20-F
Ended Dec 31
Annual report for the period ended Dec 31, 2024
Mar 10
Current report
6-K
Current report
Mar 7
Current report
6-K
Current report
2024
Dec 31
Current report
6-K
Current report
Dec 23
Current report
6-K
Current report
Dec 19
Current report
6-K
Current report
Dec 2
Current report
6-K
Current report
Nov 19
Current report
6-K
Current report
Sep 3
Current report
6-K
Current report
Aug 26
Current report
6-K
Current report
Showing 1–50 of 66 documents
Key facts
CIK
1799207
CUSIP
L0415A103
13F (30d)
13 filings
12 filers
Visit website
Investor relations